Home » Stocks » BRKR

Bruker Corporation (BRKR)

Stock Price: $69.33 USD 1.13 (1.66%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 10.51B
Revenue (ttm) 1.99B
Net Income (ttm) 157.80M
Shares Out 153.40M
EPS (ttm) 1.32
PE Ratio 52.48
Forward PE 39.37
Dividend $0.12
Dividend Yield 0.17%
Trading Day May 7
Last Price $69.33
Previous Close $68.20
Change ($) 1.13
Change (%) 1.66%
Day's Open 68.42
Day's Range 68.00 - 70.08
Day's Volume 359,317
52-Week Range 36.73 - 71.28

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Large-caps bring stability to your portfolio because they don't react as aggressively to news and other events.

Other stocks mentioned: ON, TT, UAA, VWAGY, XRAY
17 hours ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences: BofA Securities 2021 Health Care Conference Tuesday, May 11...

1 day ago - Business Wire

Bruker (BRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 day ago - Zacks Investment Research

Bruker's (BRKR) robust performances across segments and geographies manage to drive its Q1 sales despite pandemic-led business challenges.

1 day ago - Zacks Investment Research

Bruker Corp (NASDAQ: BRKR) reported first-quarter FY21 revenue growth of 30.8% year-on-year to $554.7 million, beating the analyst consensus of $513.06 million. Revenue increased by 23.8% on an organic ...

2 days ago - Benzinga

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2021. First Quarter 2021 Financial Results Bruker's revenues ...

3 days ago - Business Wire

Bruker's (BRKR) revenue improvement in the first quarter is likely to have been boosted by robust performance by all three of its BSI groups.

3 weeks ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 - $554 million, representing report...

3 weeks ago - Business Wire

Indexes Make Up Lost Ground; Strong Moves In Nvidia and Yeti, Bruker Sets Up

YouTube video

Indexes make up lost ground; Strong moves in Nvidia and Yeti, Bruker sets up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data,...

Other stocks mentioned: NVDA, YETI
3 weeks ago - Investors Business Daily

Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.

1 month ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research

1 month ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs

1 month ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center

1 month ago - Business Wire

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

SAN JOSE, Calif. & BOSTON--(BUSINESS WIRE)--Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics

1 month ago - Business Wire

Bruker Corp (BRKR) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.

1 month ago - Zacks Investment Research

CHARLESTON, S.C., March 10, 2021 /PRNewswire/ -- GlycoPath Inc., the developer of advanced bioanalytical assays based on its proprietary GlycoTyperTM immunoaffinity technology, announced the closing of ...

1 month ago - PRNewsWire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021

1 month ago - Business Wire

MUNICH--(BUSINESS WIRE)--Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurement

2 months ago - Business Wire

Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.

2 months ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at Investor Conferences

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend

2 months ago - Business Wire

Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.

2 months ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results

2 months ago - Business Wire

Bruker (NASDAQ:BRKR) unveils its next round of earnings this Tuesday, February 16. Get prepared with Benzinga's ultimate preview for Bruker's Q4 earnings.

2 months ago - Benzinga

Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast

3 months ago - Business Wire

CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a collaboratio...

3 months ago - Business Wire

4 Stocks to Watch on Rising Demand for Scientific Instruments

Other stocks mentioned: MTD, PKI, WAT
3 months ago - Zacks Investment Research

BOSTON, United States & REGENSBURG, Germany--(BUSINESS WIRE)--NMR diagnostics company numares and Bruker Corporation sign agreement to enable advanced metabolomics-based, AI driven clinical diagnostics.

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference

4 months ago - Business Wire

BILLERICA, Mass. & ODENSE, Denmark--(BUSINESS WIRE)--Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics

4 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures

4 months ago - Business Wire

Bruker's (BRKR) winter four-plex panel is expected to facilitate diagnosis and patient management by facilitating the use of saliva samples as well.

4 months ago - Zacks Investment Research

NEHREN, Germany--(BUSINESS WIRE)--Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

4 months ago - Business Wire

Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.

4 months ago - Zacks Investment Research

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

For the month, there were 13 buys including two new positions. I made the month's purchases last Friday. With the market flying high, what bargains are out there now?

Other stocks mentioned: ABEV, AZPN, CBOE, DANOY, ED, ENB, FAF ...
5 months ago - Seeking Alpha

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference

5 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend

5 months ago - Business Wire

Bruker's (BRKR) third-quarter 2020 results reflect dismal performances by two of the reporting segments and geographies due to coronavirus-led business disruptions.

6 months ago - Zacks Investment Research

Bruker Corporation (BRKR) CEO Frank Laukien on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Bruker (BRKR) delivered earnings and revenue surprises of 27.27% and 5.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Third Quarter 2020 Financial Results

6 months ago - Business Wire

On Monday, November 02, Bruker (NASDAQ: BRKR) will release its latest earnings report. Benzinga's outlook for Bruker is included in the following report.

6 months ago - Benzinga

We discuss the 13 stocks I added to my portfolio in October. I lay out the bull case for Northwest Natural as it trades near its highest dividend yield in 10 years.

Other stocks mentioned: CAAP, CBOE, CNQ, DANOY, DEO, ENB, JNJ ...
6 months ago - Seeking Alpha

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

MADISON, Wisc.--(BUSINESS WIRE)--Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities

6 months ago - Business Wire

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on in... [Read more...]

Industry
Medical Devices
IPO Date
Aug 4, 2000
CEO
Frank Laukien
Employees
7,400
Stock Exchange
NASDAQ
Ticker Symbol
BRKR
Full Company Profile

Financial Performance

In 2020, Bruker's revenue was $1.99 billion, a decrease of -4.11% compared to the previous year's $2.07 billion. Earnings were $157.80 million, a decrease of -19.98%.

Financial Statements

Analyst Forecasts

According to 13 analysts, the average rating for Bruker stock is "Buy." The 12-month stock price forecast is 72.17, which is an increase of 4.10% from the latest price.

Price Target
$72.17
(4.10% upside)
Analyst Consensus: Buy